Clinical Trials Browser

Observational × Rituximab × 30 days × Clear all

NCT06790420 2026-05-15

RITUXIMAB BS Intravenous Infusion 100mg・500mg [Pfizer] Post-marketing Database Study

2,703 enrolled 13 charts

Infections, Lymphoma